Atlas Trials

Sequential Chemo-immunotherapy Plus Thoracic Radiotherapy for Elderly And/or Frail Stage III Non-small-cell Lung Cancer

Clinical trial NCT05557552 · RECRUITING

Trial details

NCT number
NCT05557552
Sponsor
Ruijin Hospital
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Non-small Cell Lung Cancer Stage III
Start date
2022-09-30
Primary completion
2025-09-30
Enrollment
56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.